Programming of appetite and bodyweight by the interaction of maternal diet and angiotensin during peri-natal life. The project describes a phenotype for appetite and body weight that can be altered by maternal dietary omega-3 PUFA (environmental factors), at a critical period during peri-natal life (developmental phase) and that the effect on body weight is opposite when endogenous angiotensin is increased (hormonal factor). The project aims to discover how these different factors interact to p ....Programming of appetite and bodyweight by the interaction of maternal diet and angiotensin during peri-natal life. The project describes a phenotype for appetite and body weight that can be altered by maternal dietary omega-3 PUFA (environmental factors), at a critical period during peri-natal life (developmental phase) and that the effect on body weight is opposite when endogenous angiotensin is increased (hormonal factor). The project aims to discover how these different factors interact to produce the phenotype by defining the critical period and systematically identifying genes that are expressed during this period. The effect of manipulating maternal dietary omega-3 PUFA and the role of angiotensin will then be examined. The project will discover how genetic, hormonal and environmental factors interact during the perinatal period of life to program food intake and body weight in adult life. Read moreRead less
Dairy Milk Phospholipids in the Prevention of Atherosclerosis. The present project is expected to provide novel information pertaining to the separation of phospholipid (PL) fractions from buttermilk. In addition, it will generate scientific/medical knowledge concerning the use of dietary PL preparations in the prevention of arterial atherosclerosis. Together, this innovative research will help support the commercial development of PL separation from buttermilk. It will also lay the ground-wo ....Dairy Milk Phospholipids in the Prevention of Atherosclerosis. The present project is expected to provide novel information pertaining to the separation of phospholipid (PL) fractions from buttermilk. In addition, it will generate scientific/medical knowledge concerning the use of dietary PL preparations in the prevention of arterial atherosclerosis. Together, this innovative research will help support the commercial development of PL separation from buttermilk. It will also lay the ground-work for additional studies into the therapeutic benefit of dietary PLs and the commercialization of milk PL as a nutraceutical or functional food. The present project thus has significant academic, commercial and therapeutic value of potential benefit to all Australians.Read moreRead less